Today's Date: September 23, 2021
32 NFL Quarterbacks Unite to Honor Bart Starr and Raise Funds for Pediatric Cancer Research   •   Skechers Announces Updated Fireside Chat Time at the Morgan Stanley Virtual Global Sporting Goods Day   •   A New 3D Kirby Game, First Look at Bayonetta 3 and a Massive Expansion for MONSTER HUNTER RISE Highlight the Latest Nintendo Dir   •   DKT International Publishes 2020 Contraceptive Social Marketing Statistics   •   Federal Title & Escrow Company Donates to Women's Organization Working to End Homelessness in Nation's Capital   •   Barron’s Names Edelman Financial Engines America’s Top Independent Registered Investment Advisor   •   Virginia GrandDriver Goes Retro with New 80's-Themed Workout Series Aimed to Help Older Drivers Get Fit, Drive Safely, and Have   •   At-Risk Shelter Dogs Given Another Chance at Life with Veterans and Inmates through Marley's Mutts ® Pawsitive Change Progra   •   In Memoriam: Pacific Islanders in Communication Mourns the Passing of Beloved Executive Director, Leanne Ferrer   •   PEWIN Announces 2021 Annual LP/GP Awards Recipients   •   DeAndre Hopkins, NFL FLAG, Arizona Cardinals Debut DeAndre Hopkins NFL FLAG Football   •   Naples Soap Co. Signs Lease for a New Store Location in Kissimmee, Fla.   •   Chicago Children's Museum Launches Construction Of Its Newest Exhibit, Moen Presents Water City   •   Athletic Brewing, the Brewer Leading the Non-Alcoholic Craft Beer Movement, Takes Home Top Awards at Three Major Beer Competitio   •   Photographer Merik Goma To Begin Artist In Residence At The Amistad Center   •   SICO Paint by PPG Unveils 2022 Colour of the Year: Cool Current   •   The Boston Globe To Launch "Black News Hour," Hosting Boston Mayoral Candidates For Debut Episode September 24th   •   Ovarian CanceRx: New Innovative Clinical Research Effort Seeks to Accelerate the Development of New Treatments for Deadliest Gyn   •   Strategic Objectives Co-Founders Awarded CPRS National's 2021 Entrepreneurial Leadership Award   •   HERO Beverage Co. Launches a Line of Coffee Honoring the Late Chris Kyle
Bookmark and Share

Psomagen, Inc. Expands into Women’s Health Testing with Vaginal Microbiome Research Study - The VProject

ROCKVILLE, Md. , September 15 /Businesswire/ - Psomagen Inc., a CLIA-certified genetic analysis provider, is expanding its at-home testing services to include routine women’s health screening. This move began with The VProject, which is recruiting 1,000 women aged 18 and older in the United States to participate in a vaginal microbiome research study. For their involvement, participants receive a no-cost personalized test of their vaginal microbiome which can be used to understand the state of their vaginal health. As a way to express appreciation to the participants, Psomagen will also offer a no-cost gut microbiome test after the completion of the study.

The goal of the study is to gain more knowledge of the vaginal microbiome and help women take control of their health by understanding the factors behind certain conditions such as bacterial vaginosis and sexually transmitted infections.

“We believe our test can provide clinicians and patients with a more comprehensive understanding of the vaginal microbiome,” said Ryan Kim, CEO at Psomagen. “Our goal is to help women to be more proactive about their vaginal health by providing comprehensive information about potential pathogens and cervical cancer.”

Although the growth into women’s health is new to the company, the technology and science behind the analysis for these tests is familiar to its scientists.

“The process is similar to our gut microbiome analysis test, from sampling to sequencing, to delivery of results,” says Harold Nuñez, Ph.D., DTC General Manager at Psomagen. “But the results will be incredibly insightful for women since the vaginal microbiome is known to be linked to certain health conditions such as vaginal dysbiosis, infertility, and susceptibility to sexually transmitted diseases. This analysis will help us understand how lifestyle factors can impact the vaginal microbiome and women’s health overall.”

At-home diagnostic testing has become a recent trend in the health and wellness space, a growing industry that has flourished from its roots in testing for genetic traits and ancestry. Currently, Psomagen offers three at-home testing kits - Gene & GutBiome, GutBiome+, and an FDA EUA COVID-19 at-home testing kit. Women interested in participating in The VProject can enroll at

About Psomagen, Inc.

Psomagen, Inc., formerly Macrogen USA, delivers genetic sequencing services to the clinical, academic, and consumer markets. Psomagen’s labs are US-based and CLIA and CAP certified, which means they are accredited to perform high-quality Next-Generation Sequencing, Sanger Sequencing, and Microarray Analysis. Their offerings include gut microbiome testing, genetic trait analysis, vaginal microbiome health, and more. Learn more about research services at or their direct-to-consumer testing options at

STORY TAGS: Maryland, Health, Consumer, Women, General Health, Research, Science, United States, North America, Product/Service,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News